Efficacy and Safety of Secukinumab in Elderly Subjects with Moderate to Severe Plaque Psoriasis: A Pooled Analysis of Phase III Studies

Drugs & Aging ◽

10.1007/s40266-018-0520-z ◽

2018 ◽

Vol 35 (2) ◽

pp. 135-144 ◽

Author(s):

Andreas Körber ◽

Charis Papavassilis ◽

Vaishali Bhosekar ◽

Maximilian Reinhardt

Keyword(s):

Plaque Psoriasis ◽

Pooled Analysis ◽

Phase Iii ◽

Elderly Subjects ◽

Efficacy And Safety ◽

Severe Plaque Psoriasis ◽

Phase Iii Studies

Download Full-text

Secukinumab was efficacious across body regions affected by moderate to severe plaque psoriasis: Pooled analysis of phase III studies

Journal of the American Academy of Dermatology ◽

10.1016/j.jaad.2015.02.1002 ◽

2015 ◽

Vol 72 (5) ◽

pp. AB251

Keyword(s):

Plaque Psoriasis ◽

Pooled Analysis ◽

Phase Iii ◽

Severe Plaque Psoriasis ◽

Body Regions ◽

Phase Iii Studies

Download Full-text

Efficacy and safety of secukinumab by age group in patients with moderate-to-severe plaque psoriasis: Pooled analysis of 4 phase III trials

Journal of the American Academy of Dermatology ◽

10.1016/j.jaad.2016.02.965 ◽

2016 ◽

Vol 74 (5) ◽

pp. AB247

Keyword(s):

Plaque Psoriasis ◽

Pooled Analysis ◽

Phase Iii ◽

Age Group ◽

Efficacy And Safety ◽

Severe Plaque Psoriasis ◽

Phase Iii Trials

Download Full-text

Secukinumab was efficacious in the treatment of moderate to severe plaque psoriasis on the head and neck: Pooled analysis of phase III studies

Journal of the American Academy of Dermatology ◽

10.1016/j.jaad.2015.02.1004 ◽

2015 ◽

Vol 72 (5) ◽

pp. AB252

Keyword(s):

Head And Neck ◽

Plaque Psoriasis ◽

Pooled Analysis ◽

Phase Iii ◽

Severe Plaque Psoriasis ◽

Phase Iii Studies

Download Full-text

Secukinumab was efficacious in the treatment of moderate to severe plaque psoriasis in the North American population: Pooled analysis of phase III studies

Journal of the American Academy of Dermatology ◽

10.1016/j.jaad.2015.02.1003 ◽

2015 ◽

Vol 72 (5) ◽

pp. AB251

Keyword(s):

Plaque Psoriasis ◽

North American ◽

Pooled Analysis ◽

Phase Iii ◽

North American Population ◽

American Population ◽

Severe Plaque Psoriasis ◽

The North ◽

Phase Iii Studies

Download Full-text

Secukinumab efficacy and safety in Asian subjects with moderate to severe plaque psoriasis: Pooled analysis from the FIXTURE and ERASURE phase III clinical studies

Journal of the American Academy of Dermatology ◽

10.1016/j.jaad.2015.02.994 ◽

2015 ◽

Vol 72 (5) ◽

pp. AB249

Keyword(s):

Plaque Psoriasis ◽

Clinical Studies ◽

Pooled Analysis ◽

Phase Iii ◽

Efficacy And Safety ◽

Severe Plaque Psoriasis

Download Full-text

Ixabepilone plus capecitabine in metastatic breast cancer patients with reduced performance status previously treated with anthracyclines and taxanes: a pooled analysis by performance status of efficacy and safety data from 2 phase III studies

Breast Cancer Research and Treatment ◽

10.1007/s10549-010-1251-y ◽

2010 ◽

Vol 125 (3) ◽

pp. 755-765 ◽

Author(s):

Henri Roché ◽

Pierfranco Conte ◽

Edith A. Perez ◽

Joseph A. Sparano ◽

Binghe Xu ◽

...

Keyword(s):

Breast Cancer ◽

Performance Status ◽

Safety Data ◽

Metastatic Breast ◽

Pooled Analysis ◽

Phase Iii ◽

Efficacy And Safety ◽

Breast Cancer Patients ◽

Previously Treated ◽

Phase Iii Studies

Download Full-text

Efficacy and Safety of HLX03, an Adalimumab Biosimilar, in Patients with Moderate-to-Severe Plaque Psoriasis: A Randomized, Double-Blind, Phase III Study

Advances in Therapy ◽

10.1007/s12325-021-01899-0 ◽

2021 ◽

Author(s):

Lin Cai ◽

Linfeng Li ◽

Hao Cheng ◽

Yangfeng Ding ◽

Zhenshu Biao ◽

...

Keyword(s):

Plaque Psoriasis ◽

Phase Iii ◽

Efficacy And Safety ◽

Double Blind ◽

Severe Plaque Psoriasis ◽

Phase Iii Study

Download Full-text

Efficacy and safety of clindamycin phosphate 1.2%/tretinoin 0.025% formulation for the treatment of acne vulgaris: pooled analysis of data from three randomised, double-blind, parallel-group, phase III studies

European Journal of Dermatology ◽

10.1684/ejd.2014.2293 ◽

2014 ◽

Vol 24 (2) ◽

pp. 201-209 ◽

Author(s):

Brigitte Dréno ◽

Vincenzo Bettoli ◽

Falk Ochsendorf ◽

Alison M. Layton ◽

Montserrat Perez ◽

...

Keyword(s):

Acne Vulgaris ◽

Pooled Analysis ◽

Phase Iii ◽

Efficacy And Safety ◽

Clindamycin Phosphate ◽

Double Blind ◽

Parallel Group ◽

Phase Iii Studies

Download Full-text

Correction to: Efficacy and Safety of Switching to Ixekizumab in Etanercept Non-Responders: A Subanalysis from Two Phase III Randomized Clinical Trials in Moderate-to-Severe Plaque Psoriasis (UNCOVER-2 and -3)

American Journal of Clinical Dermatology ◽

10.1007/s40257-018-0353-x ◽

2018 ◽

Vol 19 (3) ◽

pp. 457-457 ◽

Author(s):

Andrew Blauvelt ◽

Kim A. Papp ◽

Christopher E. M. Griffiths ◽

Luis Puig ◽

Jamie Weisman ◽

...

Keyword(s):

Clinical Trials ◽

Plaque Psoriasis ◽

Randomized Clinical Trials ◽

Phase Iii ◽

Efficacy And Safety ◽

Two Phase ◽

Severe Plaque Psoriasis

Download Full-text

Tofacitinib, an oral Janus kinase inhibitor, for the treatment of chronic plaque psoriasis: Long-term efficacy and safety results from 2 randomized phase-III studies and 1 open-label long-term extension study

Journal of the American Academy of Dermatology ◽

10.1016/j.jaad.2016.01.013 ◽

2016 ◽

Vol 74 (5) ◽

pp. 841-850 ◽

Author(s):

Kim A. Papp ◽

James G. Krueger ◽

Steven R. Feldman ◽

Richard G. Langley ◽

Diamant Thaci ◽

...

Keyword(s):

Plaque Psoriasis ◽

Kinase Inhibitor ◽

Janus Kinase ◽

Phase Iii ◽

Efficacy And Safety ◽

Chronic Plaque Psoriasis ◽

Janus Kinase Inhibitor ◽

Phase Iii Studies

Download Full-text